Compass Pathways PLC
NASDAQ:CMPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Compass Pathways PLC
NASDAQ:CMPS
|
UK |
|
AMN Healthcare Services Inc
NYSE:AMN
|
US |
|
Corvex, Inc
NASDAQ:MOVE
|
US |
|
K
|
Kerry Properties Ltd
F:KR3
|
HK |
|
Disco Corp
F:D650
|
JP |
|
D
|
Disco Corp
F:D65
|
JP |
Intrinsic Value
Is CMPS undervalued or overvalued?
See the intrinsic value estimate for Compass Pathways PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CMPS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CMPS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Compass Pathways Does
Compass Pathways is a biotechnology company focused on developing psilocybin-based treatments for mental health conditions, especially difficult-to-treat depression. It is trying to turn a psychedelic compound into a controlled prescription medicine that can be used in a medical setting with therapist support.
- Headquarters
- United Kingdom UK
- Employees
- 156
- IPO date
- Sep 18, 2020
Earnings Waterfall
Compass Pathways PLC
The intrinsic value for Compass Pathways PLC (CMPS) under the Base Case is hidden USD.
Compared with the current market price of 11.63 USD, the stock appears hidden.